Senior insider sale
Chief Scientific Officer at MOONLAKE IMMUNOTHERAPEUTICS — senior position signals high conviction
$2.85M
150K shares
What this filing means
REICH KRISTIAN plans to sell 150K shares of MOONLAKE IMMUNOTHERAPEUTICS valued at approximately $2.85M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/15/2026ACC: 0001969223-26-000703
Officer· Chief Scientific Officer
Since Apr 2022
150K
Shares to sell
$2.85M
Approx. market value
150K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exchange of shares
NA
4/5/2023
150KTotal acquired150K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/5/2023 | Exchange of shares NA | 150K | — |
| Total | 150K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
150K
Market value
$2.85M
6/15/2026
Total
Units
150K
Value
$2.85M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/15/2026 | 150K | $2.85M | Nasdaq | Planned |
| Total | 150K | $2.85M | ||